Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools
批准号:
9905568
负责人:
DAVID J SEGAL
金额:
$116.14万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-15 至 2024-03-31
关键词:
AddressAnimal ModelAnimal TestingAnimalsBenchmarkingBiological AssayCaliforniaCallithrixCenter for Translational Science ActivitiesClinical SciencesCollaborationsCommunicationCommunitiesDevelopmentEnsureEvaluationFeedbackFosteringFundingFutureGenomeGoalsGoverning BoardHome environmentHumanInflammationInfrastructureLeadershipMacaca mulattaMethodologyModelingOffice of Administrative ManagementPopulationPositioning AttributePrimatesProceduresProcessPublicationsReagentReporterResearchResearch PersonnelResourcesSafetyScheduleScientistSpecificitySystemTechnologyTestingTranslationsUnited States National Institutes of HealthUniversitiesWorkbasedata exchangeexperiencegenome editinghuman diseaseimmunogenicityin vivoinnovationmeetingsmembermultidisciplinarynonhuman primateorganizational structureprogramsresponsesomatic cell gene editingsynergismtoolworking group
中文摘要
整体
项目总结/摘要
美国加州大学戴维斯分校非人灵长类动物体细胞评估测试中心
基因组编辑工具将支持非人类灵长类动物的研究,这将推动基因组编辑领域的发展,
并对这些技术在未来用于治疗人类疾病做出重大贡献。
非人类灵长类动物检测中心汇集了一个强大的多学科研究团队,
利用加州大学戴维斯分校的主要优势,包括加州国家灵长类动物园的校园合作伙伴关系
研究中心,基因组中心,临床和转化科学中心。非人灵长类
测试中心将为体细胞基因组编辑(SCGE)获奖者提供最先进的功能,
在非人类灵长类动物中进行高质量的研究。非人类灵长类动物检测中心利用
一个支持性框架,表明长期致力于提供研究机会
与全国各地的调查人员合作通过这种强大的基础设施,
考试中心提出以下具体目标:(1)提供一个行政和组织结构
推进非人灵长类动物体细胞基因组编辑研究,(2)与SCGE建立伙伴关系
通过提供资源,加速他们的研究,获奖者,(3)确保协同作用,
SCGE计划和联盟通过与传播和协调中心的透明互动,
SCGE工作组和项目指导委员会以及NIH。我们强大的多学科团队
准备把加州大学戴维斯分校非人类灵长类动物测试中心的深度和广度,
体细胞基因组编辑工具,以支持全国SCGE研究人员,并大大有助于
共同基金SCGE计划。
英文摘要
Overall
PROJECT SUMMARY / ABSTRACT
The University of California (UC) Davis Nonhuman Primate Testing Center for Evaluation of Somatic Cell
Genome Editing Tools will support studies in nonhuman primates that will advance the genome editing field,
and significantly contribute to the future translation of these technologies for the treatment of human disease.
The Nonhuman Primate Testing Center brings together a robust team of multidisciplinary investigators with
campus partnerships that capitalize on major strengths at UC Davis including the California National Primate
Research Center, Genome Center, and Clinical and Translational Science Center. The Nonhuman Primate
Testing Center will offer state-of-the-art capabilities for Somatic Cell Genome Editing (SCGE) awardees to
conduct high quality research in nonhuman primates. The Nonhuman Primate Testing Center leverages a
supportive framework that has demonstrated a long-standing commitment to providing research opportunities
and collaborations to investigators nationwide. Through this powerful infrastructure the Nonhuman Primate
Testing Center proposes the following Specific Aims: (1) Provide an administrative and organizational structure
to advance somatic cell genome editing studies in nonhuman primates, (2) Foster partnerships with SCGE
awardees through provision of resources that accelerate their research, and (3) Ensure synergism across the
SCGE Program and Consortium via transparent interactions with the Dissemination and Coordinating Center,
SCGE Working Group and Program Steering Committee, and the NIH. Our robust multidisciplinary team is
poised to bring the depth and breadth of the UC Davis Nonhuman Primate Testing Center for Evaluation of
Somatic Cell Genome Editing Tools to support SCGE investigators nationwide and contribute substantially to
the Common Fund SCGE Program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genome Editing and Biological Effects Testing Component
-
批准号:10773949
-
项目类别:
-
资助金额:$65.19万
-
财政年份:2023
-
负责人:DAVID J SEGAL
-
依托单位:
Innovative Translational Imaging Technologies to Monitor Genome Edited Cells in Vivo
-
批准号:10472034
-
项目类别:
-
资助金额:$47.13万
-
财政年份:2021
-
负责人:DAVID J SEGAL
-
依托单位:
Innovative Translational Imaging Technologies to Monitor Genome Edited Cells in Vivo
-
批准号:10447268
-
项目类别:
-
资助金额:$46.4万
-
财政年份:2021
-
负责人:DAVID J SEGAL
-
依托单位:
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools: Equipment Supplement
-
批准号:10330336
-
项目类别:
-
资助金额:$9.72万
-
财政年份:2021
-
负责人:DAVID J SEGAL
-
依托单位:
Innovative Translational Imaging Technologies to Monitor Genome Edited Cells in Vivo
-
批准号:9810511
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Genome Editing Testing Core
-
批准号:10380051
-
项目类别:
-
资助金额:$104.38万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools
-
批准号:9770048
-
项目类别:
-
资助金额:$116.87万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Innovative Translational Imaging Technologies to Monitor Genome Edited Cells in Vivo
-
批准号:10017228
-
项目类别:
-
资助金额:$22.79万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Genome Editing Testing Core
-
批准号:10599929
-
项目类别:
-
资助金额:$93.79万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Determinants of Persistence in Epigenetic Editing
-
批准号:9920184
-
项目类别:
-
资助金额:$18.72万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Genome Editing Testing Core
-
批准号:10133176
-
项目类别:
-
资助金额:$98.39万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
CRISPR-based epigenetic modifier
-
批准号:9369533
-
项目类别:
-
资助金额:$2.31万
-
财政年份:2017
-
负责人:DAVID J SEGAL
-
依托单位:
CRISPR-based epigenetic modifiers
-
批准号:9480886
-
项目类别:
-
资助金额:$6.85万
-
财政年份:2016
-
负责人:DAVID J SEGAL
-
依托单位:
CRISPR-based epigenetic modifiers
-
批准号:9301498
-
项目类别:
-
资助金额:$31.63万
-
财政年份:2016
-
负责人:DAVID J SEGAL
-
依托单位:
NextGen DNA Binding Proteins Based on TAL Domains
-
批准号:8641394
-
项目类别:
-
资助金额:$27.75万
-
财政年份:2011
-
负责人:DAVID J SEGAL
-
依托单位:
NextGen DNA Binding Proteins Based on TAL Domains
-
批准号:8449290
-
项目类别:
-
资助金额:$26.87万
-
财政年份:2011
-
负责人:DAVID J SEGAL
-
依托单位:
NextGen DNA Binding Proteins Based on TAL Domains
-
批准号:8245004
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2011
-
负责人:DAVID J SEGAL
-
依托单位:
NextGen DNA Binding Proteins Based on TAL Domains
-
批准号:8083281
-
项目类别:
-
资助金额:$26.91万
-
财政年份:2011
-
负责人:DAVID J SEGAL
-
依托单位:
Towards Gene Therapy for Angelman Syndrome
-
批准号:7970962
-
项目类别:
-
资助金额:$17.91万
-
财政年份:2010
-
负责人:DAVID J SEGAL
-
依托单位:
Towards Gene Therapy for Angelman Syndrome
-
批准号:8139031
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2010
-
负责人:DAVID J SEGAL
-
依托单位:
海外基金